NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Resverlogix Corp (F: RFS)

 
RFS Technical Analysis
5
As on 11th Jul 2023 RFS STOCK Price closed @ 0.08 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.20 & Strong Sell for SHORT-TERM with Stoploss of 0.38 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

RFSSTOCK Price

Open 0.07 Change Price %
High 0.08 1 Day 0.02 33.33
Low 0.07 1 Week 0.03 60.00
Close 0.08 1 Month 0.01 14.29
Volume 2000 1 Year -0.40 -83.33
52 Week High 0.52 | 52 Week Low 0.05
 
F Germany Most Active Stocks
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
TOE 0.02 0.00%
 
F Germany Top Gainers Stocks
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
8S3B 1.73 620.83%
8S3B 1.73 620.83%
SY7P 0.07 600.00%
P9F1 1.75 326.83%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
AETG 0.25 -91.61%
AETG 0.25 -91.61%
 
 
RFS
Daily Charts
RFS
Intraday Charts
Whats New @
Bazaartrend
RFS
Free Analysis
 
RFS Important Levels Intraday
RESISTANCE0.10
RESISTANCE0.09
RESISTANCE0.09
RESISTANCE0.09
SUPPORT0.07
SUPPORT0.07
SUPPORT0.07
SUPPORT0.06
 
RFS Forecast May 2024
4th UP Forecast0.54
3rd UP Forecast0.39
2nd UP Forecast0.3
1st UP Forecast0.21
1st DOWN Forecast-0.05
2nd DOWN Forecast-0.14
3rd DOWN Forecast-0.23
4th DOWN Forecast-0.38
 
RFS Weekly Forecast
4th UP Forecast0.23
3rd UP Forecast0.18
2nd UP Forecast0.15
1st UP Forecast0.12
1st DOWN Forecast0.04
2nd DOWN Forecast0.01
3rd DOWN Forecast-0.02
4th DOWN Forecast-0.07
 
RFS Forecast2024
4th UP Forecast0.99
3rd UP Forecast0.7
2nd UP Forecast0.52
1st UP Forecast0.34
1st DOWN Forecast-0.18
2nd DOWN Forecast-0.36
3rd DOWN Forecast-0.54
4th DOWN Forecast-0.83
 
 
RFS Other Details
Segment EQ
Market Capital 86207960.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
RFS Address
RFS
 
RFS Latest News
 
Your Comments and Response on Resverlogix Corp
 
RFS Business Profile
Resverlogix Corp. operates as a late-stage clinical biotechnology company. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular, end-stage renal, chronic kidney, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the initial commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada. Address: 4820 Richard Road SW, Calgary, AB, Canada, T3E 6L1
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service